Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Omicron Infection Likely to Protect You Against Flu, Says Testing Expert
The autumn rollout of the Covid and flu vaccines will generally involve everyone eligible for both […]
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the […]
GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study
GenScript USA Inc., the world’s leading life-science research tools and services provider, is collaborating with researchers at […]
Gilead Sciences Completes Acquisition of MiroBio
GMiroBioilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to […]
Aberdeen Dermatology Associates Is First in South Dakota to Offer Non-Surgical Technology for Treating Common Skin Cancers
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided […]
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
Johnson & Johnson (NYSE: JNJ) (the Company) today opened its San Francisco Bay Campus, a […]
Covalab, Cimcure and Partners Receive €1.06M EUREKA Eurostars Grant to Develop New Combination Therapy for Glioblastoma
Covalab, a biotechnology company that specializes in the development and production of recombinant proteins and […]
Calliditas’ Partner STADA Launches the First Medicine Authorized in the EU for Treating Primary IgA Nephropathy
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its European commercial […]
Breakthrough RNA-based Anti-CancerImmunotherapy Treatments Being Developed by Global Consortium Led by the Hadassah Cancer Research Institute
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, announced today […]
Advanced NanoTherapies' SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease
Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease’s most significant […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more